Dermapharm Holding SE (DMP) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Merck KGaA

Dermapharm Holding SE

PharmaSGP Holding SE

Bayer AG

Evotec SE

Formycon AG

Heidelberg Pharma AG

PAION AG

Haemato AG

APONTIS PHARMA AG

Biofrontera AG

Why is Dermapharm Holding SE ?

High Management Efficiency with a high ROCE of 22.43%

High Debt Company with a Debt to Equity ratio (avg) at times

High Debt Company with a Debt to Equity ratio (avg) at times

The company has declared Negative results for the last 3 consecutive quarters

OPERATING PROFIT TO INTEREST(Q) Lowest at 2.27 times
PAT(Q) At EUR -3 MM has Fallen at -111.8 %
OPERATING CF(Y) Lowest at EUR 191.09 MM

With ROE of 17.05%, it has a Expensive valuation with a 2.91 Price to Book Value

The stock is trading at a discount compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 2.99%, its profits have risen by 20.5% ; the PEG ratio of the company is 0.8

Underperformed the market in the last 1 year

The stock has generated a return of 2.99% in the last 1 year, much lower than market (Germany DAX (TR)) returns of 24.35%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Dermapharm Holding SE should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Dermapharm Holding SE for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Dermapharm Holding SE

7.95%

-0.46

27.92%

Germany DAX (TR)

18.37%

1.26

19.31%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

8.81%

EBIT Growth (5y)

8.82%

EBIT to Interest (avg)

12.81

Debt to EBITDA (avg)

2.01

Net Debt to Equity (avg)

1.38

Sales to Capital Employed (avg)

0.84

Tax Ratio

35.83%

Dividend Payout Ratio

42.59%

Pledged Shares

Institutional Holding

0.12%

ROCE (avg)

22.43%

ROE (avg)

27.04%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.91

EV to EBIT

12.16

EV to EBITDA

8.64

EV to Capital Employed

1.81

EV to Sales

2.21

PEG Ratio

0.83

Dividend Yield

ROCE (Latest)

14.86%

ROE (Latest)

17.05%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

Mildly Bullish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is working for Dermapharm Holding SE

Debtors Turnover Ratio- Half Yearly

Highest at 12.49 times

in the last five half yearly periods

MOJO Watch

Company has been able to settle its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Dermapharm Holding SE

Operating Profit to Interest - Quarterly

Lowest at 2.27 times and Fallen

in each of the last 5 periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest (EUR MM)

Profit After Tax (PAT) - Quarterly

At EUR -3 MM has Fallen at -111.8 %

over average PAT of the previous four periods of EUR 29 MM

MOJO Watch

Near term PAT trend is very negative

PAT (EUR MM)

Interest - Quarterly

At EUR 29 MM has Grown at 80.77 %

Quarter on Quarter (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (EUR MM)

Profit Before Tax less Other Income (PBT) - Quarterly

At EUR 2 MM has Fallen at -96.0 %

over average PBT of the previous four periods of EUR 57 MM

MOJO Watch

Near term PBT trend is very negative

PBT less Other Income (EUR MM)

Operating Cash Flow - Annually

Lowest at EUR 191.09 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (EUR MM)

Interest - Quarterly

Highest at EUR 29 MM

in the last five periods and Increased by 80.77 % (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (EUR MM)

Operating Profit (PBDIT) - Quarterly

Lowest at EUR 66 MM.

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (EUR MM)

Operating Profit Margin - Quarterly

Lowest at 24.54%

in the last five quarters

MOJO Watch

Company's efficiency has deteriorated

Operating Profit to Sales (EUR MM)

Profit Before Tax less Other Income (PBT) - Quarterly

Lowest at EUR 2 MM.

in the last five periods

MOJO Watch

Near term PBT trend is negative

PBT less Other Income (EUR MM)

Dividend Payout Ratio (DPR) - Annually

Lowest at 0.00 %

in the last five years

MOJO Watch

Company is distributing lower proportion of profits generated as dividend

DPR (%)